Ipca has struck a deal to take full ownership of US firm Bayshore Pharmaceuticals by acquiring the remaining 20% stake that it did not already own.
Indian active pharmaceutical ingredient and formulations firm Ipca Laboratories has struck a deal to take full ownership of US generics player Bayshore Pharmaceuticals by acquiring the remaining 20% stake in Bayshore that it does not already own for $1.2m in cash.
“With this acquisition, Bayshore is now wholly owned by Ipca Pharmaceuticals Inc, a wholly-owned subsidiary of the company,” the firm...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
